SCHEMBL30171213

SCHEMBL30171213

Cc1cccc(Oc2nc3c(c(=O)n(CCCO)c(=O)n3C)n2Cc2ccc(Cl)cn2)c1

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPC5 Q9UL62 4/20 0.70
TRPC4 Q9UBN4 2/20 0.70
KCNH2 Q12809 1/20 0.70
TRPC1 P48995 1/20 0.64
TSHR P16473 3/20 0.53
MEN1 O00255 2/20 0.53
ALDH1A1 P00352 2/20 0.53
KMT2A Q03164 2/20 0.53
HTT P42858 1/20 0.51
THRB P10828 1/20 0.48
TP53 P04637 2/20 0.46
LMNA P02545 1/20 0.44
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
HIF1A Q16665 1/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16027657 1.00 TRPC5 (0.70) TRPC5TRPC4KCNH2TRPC1TSHR
SCHEMBL30171354 0.94 TRPC5 (0.80) TRPC5TRPC4KCNH2TRPC1TSHR
SCHEMBL16028521 0.94 TRPC5 (0.80) TRPC5TRPC4KCNH2TRPC1TSHR
SCHEMBL16028293 0.93 TRPC5 (0.71) TRPC5TRPC4KCNH2TRPC1TSHR
SCHEMBL16028337 0.91 TRPC5 (0.69) TRPC5TRPC4KCNH2TRPC1TSHR
SCHEMBL16028445 0.91 TRPC4 (0.67) TRPC5TRPC4KCNH2TRPC1MEN1
SCHEMBL16028465 0.91 TRPC5 (0.70) TRPC5TRPC4KCNH2TRPC1TSHR
SCHEMBL16028347 0.90 TRPC5 (0.61) TRPC5TRPC4KCNH2TRPC1TSHR
SCHEMBL30171286 0.90 TRPC5 (0.67) TRPC5TRPC4KCNH2TRPC1TSHR
SCHEMBL16076066 0.90 TRPC5 (0.67) TRPC5TRPC4KCNH2TRPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034143-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2025-01-30 US disclosed
US-11958854-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2024-04-16 US disclosed
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11958854-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 TRPC5 1/4885TRPC4 3/4885KCNH2 70/4885
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TRPC5 1/4885TRPC4 3/4885KCNH2 70/4885
US-20250034143-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 TRPC5 1/4885TRPC4 3/4885KCNH2 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.